TG Therapeutics, Inc. (TGTX)

TG Therapeutics Revenue

TG Therapeutics had revenue of $161.71M in the quarter ending September 30, 2025, with 92.79% growth. This brings the company's revenue in the last twelve months to $531.90M, up 100.88% year-over-year. In the year 2024, TG Therapeutics had annual revenue of $329.00M with 40.80% growth.

• Revenue (ttm): $531.90M
• Revenue Growth: +100.88%
• P/S Ratio: 8.43
• Revenue / Employee: $1,573,663
• Employees: 338
• Market Cap: 4.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	329.00M	95.34M	40.80%
Dec 31, 2023	233.66M	230.88M	8,290.02%
Dec 31, 2022	2.79M	-3.90M	-58.36%
Dec 31, 2021	6.69M	6.54M	4,300.66%
Dec 31, 2020	152.00K	-	-
Dec 31, 2019	152.00K	-	-
Dec 31, 2018	152.00K	-	-
Dec 31, 2017	152.00K	-	-
Dec 31, 2016	152.00K	-381.00	-0.25%
Dec 31, 2015	152.38K	-	-
Dec 31, 2014	152.38K	-	-
Dec 31, 2013	152.38K	133.33K	699.98%
Dec 31, 2012	19.05K	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-